These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37833459)

  • 21. Vagus nerve stimulation improves locomotion and neuronal populations in a model of Parkinson's disease.
    Farrand AQ; Helke KL; Gregory RA; Gooz M; Hinson VK; Boger HA
    Brain Stimul; 2017; 10(6):1045-1054. PubMed ID: 28918943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuron-derived IgG protects dopaminergic neurons from insult by 6-OHDA and activates microglia through the FcγR I and TLR4 pathways.
    Zhang J; Niu N; Wang M; McNutt MA; Zhang D; Zhang B; Lu S; Liu Y; Liu Z
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1911-20. PubMed ID: 23791745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in rat partial and full nigral 6-hydroxydopamine lesion models of Parkinson's disease.
    Hansen HH; Fabricius K; Barkholt P; Mikkelsen JD; Jelsing J; Pyke C; Knudsen LB; Vrang N
    Brain Res; 2016 Sep; 1646():354-365. PubMed ID: 27233809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cystic fibrosis transmembrane conductance regulator-associated ligand protects dopaminergic neurons by differentially regulating metabotropic glutamate receptor 5 in the progression of neurotoxin 6-hydroxydopamine-induced Parkinson's disease model.
    Wang Y; Gu L; Yang HM; Zhang H
    Neurotoxicology; 2021 May; 84():14-29. PubMed ID: 33571554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ironing iron out in Parkinson's disease and other neurodegenerative diseases with iron chelators: a lesson from 6-hydroxydopamine and iron chelators, desferal and VK-28.
    Youdim MB; Stephenson G; Ben Shachar D
    Ann N Y Acad Sci; 2004 Mar; 1012():306-25. PubMed ID: 15105275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted inhibition of RAGE in substantia nigra of rats blocks 6-OHDA-induced dopaminergic denervation.
    Gasparotto J; Ribeiro CT; Bortolin RC; Somensi N; Rabelo TK; Kunzler A; Souza NC; Pasquali MAB; Moreira JCF; Gelain DP
    Sci Rep; 2017 Aug; 7(1):8795. PubMed ID: 28821831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transgenic Mice Overexpressing the Divalent Metal Transporter 1 Exhibit Iron Accumulation and Enhanced Parkin Expression in the Brain.
    Zhang CW; Tai YK; Chai BH; Chew KCM; Ang ET; Tsang F; Tan BWQ; Hong ETE; Asad ABA; Chuang KH; Lim KL; Soong TW
    Neuromolecular Med; 2017 Sep; 19(2-3):375-386. PubMed ID: 28695462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopaminergic neuronal death in the substantia nigra associates with change in serum levels of TNF-α and IL-1β; evidence from early experimental model of Parkinson's disease.
    Piri H; Sharifi S; Nigjeh S; Haghdoost-Yazdi H
    Neurol Res; 2022 Jun; 44(6):544-553. PubMed ID: 34986749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Relationship between Iron and LRRK2 in a 6-OHDA-Induced Parkinson's Disease Model.
    Jia R; Liu Y; Shuai K; Zhou C; Chen L; Zhu L; Wu XM
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abrogation of the Circadian Nuclear Receptor REV-ERBα Exacerbates 6-Hydroxydopamine-Induced Dopaminergic Neurodegeneration.
    Kim J; Jang S; Choi M; Chung S; Choe Y; Choe HK; Son GH; Rhee K; Kim K
    Mol Cells; 2018 Aug; 41(8):742-752. PubMed ID: 30078232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-inflammatory effects of BHBA in both in vivo and in vitro Parkinson's disease models are mediated by GPR109A-dependent mechanisms.
    Fu SP; Wang JF; Xue WJ; Liu HM; Liu BR; Zeng YL; Li SN; Huang BX; Lv QK; Wang W; Liu JX
    J Neuroinflammation; 2015 Jan; 12():9. PubMed ID: 25595674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gut microbiota-induced CXCL1 elevation triggers early neuroinflammation in the substantia nigra of Parkinsonian mice.
    Ma XZ; Chen LL; Qu L; Li H; Wang J; Song N; Xie JX
    Acta Pharmacol Sin; 2024 Jan; 45(1):52-65. PubMed ID: 37674043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polydatin Prevents Lipopolysaccharide (LPS)-Induced Parkinson's Disease via Regulation of the AKT/GSK3β-Nrf2/NF-κB Signaling Axis.
    Huang B; Liu J; Meng T; Li Y; He D; Ran X; Chen G; Guo W; Kan X; Fu S; Wang W; Liu D
    Front Immunol; 2018; 9():2527. PubMed ID: 30455692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Estrogen protects the dopaminergic neurons in substantia nigra against damage induced by 6-hydroxydopamine].
    Meng JL; Ma YY; Luo HY; Kong SZ; He YW; Dong BC; Wu SH; He M
    Sheng Li Xue Bao; 2008 Jun; 60(3):369-74. PubMed ID: 18560728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathogenic Upregulation of Glial Lipocalin-2 in the Parkinsonian Dopaminergic System.
    Kim BW; Jeong KH; Kim JH; Jin M; Kim JH; Lee MG; Choi DK; Won SY; McLean C; Jeon MT; Lee HW; Kim SR; Suk K
    J Neurosci; 2016 May; 36(20):5608-22. PubMed ID: 27194339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolonged Dysfunction of Astrocytes and Activation of Microglia Accelerate Degeneration of Dopaminergic Neurons in the Rat Substantia Nigra and Block Compensation of Early Motor Dysfunction Induced by 6-OHDA.
    Kuter K; Olech Ł; Głowacka U
    Mol Neurobiol; 2018 Apr; 55(4):3049-3066. PubMed ID: 28466266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pro-inflammatory cytokine-mediated ferroportin down-regulation contributes to the nigral iron accumulation in lipopolysaccharide-induced Parkinsonian models.
    Zhang Z; Hou L; Song JL; Song N; Sun YJ; Lin X; Wang XL; Zhang FZ; Ge YL
    Neuroscience; 2014 Jan; 257():20-30. PubMed ID: 24183966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p-Quinone mediates 6-hydroxydopamine-induced dopaminergic neuronal death and ferrous iron accelerates the conversion of p-quinone into melanin extracellularly.
    Izumi Y; Sawada H; Sakka N; Yamamoto N; Kume T; Katsuki H; Shimohama S; Akaike A
    J Neurosci Res; 2005 Mar; 79(6):849-60. PubMed ID: 15712215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroinflammation mediated by IL-1beta increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson's disease.
    Koprich JB; Reske-Nielsen C; Mithal P; Isacson O
    J Neuroinflammation; 2008 Feb; 5():8. PubMed ID: 18304357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Striatal neuroinflammation promotes Parkinsonism in rats.
    Choi DY; Liu M; Hunter RL; Cass WA; Pandya JD; Sullivan PG; Shin EJ; Kim HC; Gash DM; Bing G
    PLoS One; 2009; 4(5):e5482. PubMed ID: 19424495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.